Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 287

1.

Author Correction: A systems biology approach uncovers cell-specific gene regulatory effects of genetic associations in multiple sclerosis.

International Multiple Sclerosis Genetics Consortium.

Nat Commun. 2019 Jul 1;10(1):2956. doi: 10.1038/s41467-019-10951-1.

2.

Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk.

International Multiple Sclerosis Genetics Consortium. Electronic address: chris.cotsapas@yale.edu; International Multiple Sclerosis Genetics Consortium.

Cell. 2019 Jun 27;178(1):262. doi: 10.1016/j.cell.2019.06.016. No abstract available.

3.

The 3A6-TCR/superagonist/HLA-DR2a complex shows similar interface and reduced flexibility compared to the complex with self-peptide.

Salutari I, Martin R, Caflisch A.

Proteins. 2019 Jun 25. doi: 10.1002/prot.25764. [Epub ahead of print]

PMID:
31237711
4.

A systems biology approach uncovers cell-specific gene regulatory effects of genetic associations in multiple sclerosis.

International Multiple Sclerosis Genetics Consortium.

Nat Commun. 2019 May 20;10(1):2236. doi: 10.1038/s41467-019-09773-y. Erratum in: Nat Commun. 2019 Jul 1;10(1):2956.

5.

Brain Citrullination Patterns and T Cell Reactivity of Cerebrospinal Fluid-Derived CD4+ T Cells in Multiple Sclerosis.

Faigle W, Cruciani C, Wolski W, Roschitzki B, Puthenparampil M, Tomas-Ojer P, Sellés-Moreno C, Zeis T, Jelcic I, Schaeren-Wiemers N, Sospedra M, Martin R.

Front Immunol. 2019 Apr 10;10:540. doi: 10.3389/fimmu.2019.00540. eCollection 2019.

6.

MAPK pathway and B cells overactivation in multiple sclerosis revealed by phosphoproteomics and genomic analysis.

Kotelnikova E, Kiani NA, Messinis D, Pertsovskaya I, Pliaka V, Bernardo-Faura M, Rinas M, Vila G, Zubizarreta I, Pulido-Valdeolivas I, Sakellaropoulos T, Faigle W, Silberberg G, Masso M, Stridh P, Behrens J, Olsson T, Martin R, Paul F, Alexopoulos LG, Saez-Rodriguez J, Tegner J, Villoslada P.

Proc Natl Acad Sci U S A. 2019 May 7;116(19):9671-9676. doi: 10.1073/pnas.1818347116. Epub 2019 Apr 19.

PMID:
31004050
7.

Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk.

International Multiple Sclerosis Genetics Consortium. Electronic address: chris.cotsapas@yale.edu; International Multiple Sclerosis Genetics Consortium.

Cell. 2018 Nov 29;175(6):1679-1687.e7. doi: 10.1016/j.cell.2018.09.049. Epub 2018 Oct 18.

8.

Targeting fibrin in neurodegeneration.

Martin R.

Nat Immunol. 2018 Nov;19(11):1149-1150. doi: 10.1038/s41590-018-0241-9. Epub 2018 Oct 15. No abstract available.

PMID:
30323342
9.

GDP-l-fucose synthase is a CD4+ T cell-specific autoantigen in DRB3*02:02 patients with multiple sclerosis.

Planas R, Santos R, Tomas-Ojer P, Cruciani C, Lutterotti A, Faigle W, Schaeren-Wiemers N, Espejo C, Eixarch H, Pinilla C, Martin R, Sospedra M.

Sci Transl Med. 2018 Oct 10;10(462). pii: eaat4301. doi: 10.1126/scitranslmed.aat4301.

10.

Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis.

Jelcic I, Al Nimer F, Wang J, Lentsch V, Planas R, Jelcic I, Madjovski A, Ruhrmann S, Faigle W, Frauenknecht K, Pinilla C, Santos R, Hammer C, Ortiz Y, Opitz L, Grönlund H, Rogler G, Boyman O, Reynolds R, Lutterotti A, Khademi M, Olsson T, Piehl F, Sospedra M, Martin R.

Cell. 2018 Sep 20;175(1):85-100.e23. doi: 10.1016/j.cell.2018.08.011. Epub 2018 Aug 30.

11.

Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.

Fox RJ, Coffey CS, Conwit R, Cudkowicz ME, Gleason T, Goodman A, Klawiter EC, Matsuda K, McGovern M, Naismith RT, Ashokkumar A, Barnes J, Ecklund D, Klingner E, Koepp M, Long JD, Natarajan S, Thornell B, Yankey J, Bermel RA, Debbins JP, Huang X, Jagodnik P, Lowe MJ, Nakamura K, Narayanan S, Sakaie KE, Thoomukuntla B, Zhou X, Krieger S, Alvarez E, Apperson M, Bashir K, Cohen BA, Coyle PK, Delgado S, Dewitt LD, Flores A, Giesser BS, Goldman MD, Jubelt B, Lava N, Lynch SG, Moses H, Ontaneda D, Perumal JS, Racke M, Repovic P, Riley CS, Severson C, Shinnar S, Suski V, Weinstock-Guttman B, Yadav V, Zabeti A; NN102/SPRINT-MS Trial Investigators.

N Engl J Med. 2018 Aug 30;379(9):846-855. doi: 10.1056/NEJMoa1803583.

12.

Unfavorable Structural and Functional Outcomes in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis.

Jelcic I, Hanson JVM, Lukas S, Weber KP, Landau K, Pless M, Reindl M, Weller M, Martin R, Lutterotti A, Schippling S.

J Neuroophthalmol. 2019 Mar;39(1):3-7. doi: 10.1097/WNO.0000000000000669.

PMID:
30015656
13.

In search of cerebrospinal fluid biomarkers of fatigue in multiple sclerosis: A proteomics study.

Valko PO, Roschitzki B, Faigle W, Grossmann J, Panse C, Biro P, Dambach M, Spahn DR, Weller M, Martin R, Baumann CR.

J Sleep Res. 2019 Jun;28(3):e12721. doi: 10.1111/jsr.12721. Epub 2018 Jul 1.

PMID:
29961995
14.

Long-term exposure to air pollution and the incidence of multiple sclerosis: A population-based cohort study.

Bai L, Burnett RT, Kwong JC, Hystad P, van Donkelaar A, Brook JR, Tu K, Copes R, Goldberg MS, Martin RV, Murray BJ, Kopp A, Chen H.

Environ Res. 2018 Oct;166:437-443. doi: 10.1016/j.envres.2018.06.003. Epub 2018 Jun 22.

PMID:
29940476
15.

Understanding risk of PML through multiple sclerosis.

Martin R.

Lancet Neurol. 2018 May;17(5):391-392. doi: 10.1016/S1474-4422(18)30122-4. No abstract available.

PMID:
29656736
16.

Detailed Characterization of T Cell Receptor Repertoires in Multiple Sclerosis Brain Lesions.

Planas R, Metz I, Martin R, Sospedra M.

Front Immunol. 2018 Mar 19;9:509. doi: 10.3389/fimmu.2018.00509. eCollection 2018.

17.

Phenotypic and functional complexity of brain-infiltrating T cells in Rasmussen encephalitis.

Al Nimer F, Jelcic I, Kempf C, Pieper T, Budka H, Sospedra M, Martin R.

Neurol Neuroimmunol Neuroinflamm. 2017 Dec 8;5(1):e419. doi: 10.1212/NXI.0000000000000419. eCollection 2018 Jan.

18.

A standardised frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial).

Stürner KH, Stellmann JP, Dörr J, Paul F, Friede T, Schammler S, Reinhardt S, Gellissen S, Weissflog G, Faizy TD, Werz O, Fleischer S, Vaas LAI, Herrmann F, Pless O, Martin R, Heesen C.

J Neurol Neurosurg Psychiatry. 2018 Apr;89(4):330-338. doi: 10.1136/jnnp-2017-317101. Epub 2017 Dec 16.

PMID:
29248894
19.

Prevention and therapy of JC polyomavirus-mediated progressive multifocal leukoencephalopathy - a realistic possibility?

Jelcic I, Combaluzier B, Jelcic I, Sospedra M, Grimm J, Martin R.

Swiss Med Wkly. 2017 Oct 31;147:w14520. doi: 10.4414/smw.2017.14520. eCollection 2017.

20.

Dynamics and heterogeneity of brain damage in multiple sclerosis.

Kotelnikova E, Kiani NA, Abad E, Martinez-Lapiscina EH, Andorra M, Zubizarreta I, Pulido-Valdeolivas I, Pertsovskaya I, Alexopoulos LG, Olsson T, Martin R, Paul F, Tegnér J, Garcia-Ojalvo J, Villoslada P.

PLoS Comput Biol. 2017 Oct 26;13(10):e1005757. doi: 10.1371/journal.pcbi.1005757. eCollection 2017 Oct.

Supplemental Content

Loading ...
Support Center